Kbc Group Nv Abbott Laboratories Transaction History

Kbc Group Nv

$36.3 Billion
Q4 2024

A detailed history of Kbc Group Nv transactions in Abbott Laboratories stock. As of the latest transaction made, Kbc Group Nv holds 962,612 shares of ABT stock, worth $124 Million. This represents 0.3% of its overall portfolio holdings.

Number of Shares

962,612

Previous 1,497,747 35.73%

Holding current value

$124 Million

Previous $171 Million 36.24%

% of portfolio

0.3%

Previous 0.52%

36 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 22, 2025	SELL	$111.93 - $119.39 $59.9 Million - $63.9 Million	-535,135 Reduced 35.73%	962,612 $109 Million
Q3 2024 Nov 06, 2024	BUY	$100.07 - $118.13 $57.1 Million - $67.4 Million	570,224 Added 61.48%	1,497,747 $171 Million
Q2 2024 Jul 17, 2024	SELL	$100.73 - $112.44 $9.55 Million - $10.7 Million	-94,772 Reduced 9.27%	927,523 $96.4 Million
Q1 2024 May 08, 2024	SELL	$109.52 - $120.96 $54.3 Million - $59.9 Million	-495,390 Reduced 32.64%	1,022,295 $116 Million
Q4 2023 Feb 13, 2024	SELL	$90.19 - $110.4 $16.3 Million - $19.9 Million	-180,280 Reduced 10.62%	1,517,685 $167 Million
Q3 2023 Feb 15, 2024	BUY	$95.53 - $114.62 $7.79 Million - $9.34 Million	81,517 Added 4.8%	1,779,482 $172 Million
Q2 2023 Feb 15, 2024	BUY	$100.78 - $112.29 $21.4 Million - $23.8 Million	212,123 Added 14.28%	1,697,965 $185 Million
Q2 2023 Jul 28, 2023	SELL	$100.78 - $112.29 $5.04 Million - $5.62 Million	-50,031 Reduced 2.86%	1,697,965 $185 Million
Q1 2023 Feb 14, 2024	BUY	$96.86 - $114.01 $27 Million - $31.7 Million	278,451 Added 18.92%	1,750,516 $177 Million
Q1 2023 May 04, 2023	BUY	$96.86 - $114.01 $25.6 Million - $30.2 Million	264,807 Added 17.85%	1,747,996 $177 Million
Q4 2022 Feb 14, 2024	BUY	$95.06 - $111.52 $2.06 Million - $2.41 Million	21,623 Added 1.49%	1,472,065 $162 Million
Q3 2022 Feb 15, 2024	SELL	$96.76 - $112.03 $3.08 Million - $3.57 Million	-31,843 Reduced 2.1%	1,485,842 $144 Million
Q3 2022 Nov 08, 2022	BUY	$96.76 - $112.03 $4.23 Million - $4.89 Million	43,668 Added 3.03%	1,483,189 $144 Million
Q2 2022 Feb 14, 2024	BUY	$102.07 - $123.37 $46.9 Million - $56.7 Million	459,331 Added 46.35%	1,450,442 $158 Million
Q2 2022 Jul 26, 2022	BUY	$102.07 - $123.37 $45.8 Million - $55.3 Million	448,410 Added 45.24%	1,439,521 $156 Million
Q1 2022 Feb 14, 2024	SELL	$114.02 - $139.04 $43.7 Million - $53.3 Million	-383,159 Reduced 27.88%	991,111 $117 Million
Q1 2022 May 06, 2022	SELL	$114.02 - $139.04 $43.7 Million - $53.3 Million	-383,159 Reduced 27.88%	991,111 $117 Million
Q4 2021 Feb 14, 2024	SELL	$115.53 - $141.46 $16.6 Million - $20.3 Million	-143,415 Reduced 9.45%	1,374,270 $193 Million
Q4 2021 Feb 03, 2022	BUY	$115.53 - $141.46 $45.1 Million - $55.2 Million	390,506 Added 39.7%	1,374,270 $193 Million
Q3 2021 Nov 10, 2021	SELL	$116.66 - $129.06 $17.6 Million - $19.4 Million	-150,463 Reduced 13.27%	983,764 $116 Million
Q2 2021 Aug 11, 2021	SELL	$105.79 - $124.53 $10.8 Million - $12.7 Million	-101,879 Reduced 8.24%	1,134,227 $131 Million
Q1 2021 Apr 26, 2021	BUY	$108.84 - $128.23 $6.74 Million - $7.94 Million	61,893 Added 5.27%	1,236,106 $148 Million
Q4 2020 Feb 10, 2021	BUY	$105.0 - $114.42 $25.8 Million - $28.2 Million	246,085 Added 26.51%	1,174,213 $129 Million
Q3 2020 Oct 28, 2020	SELL	$91.64 - $111.29 $59.2 Million - $71.8 Million	-645,577 Reduced 41.02%	928,128 $101 Million
Q2 2020 Aug 10, 2020	BUY	$76.57 - $98.0 $32.2 Million - $41.2 Million	420,175 Added 36.43%	1,573,705 $144 Million
Q1 2020 May 04, 2020	BUY	$62.82 - $91.86 $31.8 Million - $46.5 Million	506,219 Added 78.2%	1,153,530 $91 Million
Q4 2019 Feb 11, 2020	SELL	$78.51 - $87.4 $5.12 Million - $5.69 Million	-65,153 Reduced 9.14%	647,311 $56.2 Million
Q3 2019 Nov 07, 2019	BUY	$81.84 - $88.74 $17 Million - $18.4 Million	207,658 Added 41.14%	712,464 $59.6 Million
Q2 2019 Jul 30, 2019	BUY	$72.88 - $85.0 $1.88 Million - $2.19 Million	25,807 Added 5.39%	504,806 $0
Q1 2019 May 10, 2019	BUY	$66.22 - $80.06 $9.44 Million - $11.4 Million	142,603 Added 42.39%	478,999 $0
Q4 2018 Jan 31, 2019	SELL	$65.56 - $74.27 $7.69 Million - $8.72 Million	-117,350 Reduced 25.86%	336,396 $24.3 Million
Q3 2018 Nov 14, 2018	BUY	$60.81 - $73.36 $344,427 - $415,511	5,664 Added 1.26%	453,746 $0
Q2 2018 Aug 03, 2018	SELL	$57.57 - $63.54 $5.48 Million - $6.05 Million	-95,165 Reduced 17.52%	448,082 $0
Q1 2018 May 09, 2018	SELL	$56.27 - $63.62 $23.4 Million - $26.5 Million	-416,614 Reduced 43.4%	543,247 $0
Q4 2017 Feb 07, 2018	SELL	$53.68 - $57.47 $15.2 Million - $16.3 Million	-283,691 Reduced 22.81%	959,861 $0
Q3 2017 Nov 13, 2017	BUY	$48.06 - $53.64 $59.8 Million - $66.7 Million	1,243,552	1,243,552 $0

Others Institutions Holding ABT

# of Institutions

3,230

Shares Held

1.3B

Call Options Held

8.71M

Put Options Held

8.03M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $226B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Kbc Group Nv, based on Form 13F filings with the SEC.

News

Stay updated on Kbc Group Nv with notifications on news.

Account